Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

Appelbaum, 2008, Allogeneic hematopoietic cell transplantation for acute myeloid leukemia when a matched related donor is not available., Hematology Am Soc Hematol Educ Program, 2008:412 Saber, 2012, Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia., Blood, 119, 3908, 10.1182/blood-2011-09-381699 Petersdorf, 2004, Limits of HLA mismatching in unrelated hematopoietic cell transplantation., Blood, 104, 2976, 10.1182/blood-2004-04-1674 Switzer, 2013, Race and ethnicity in decisions about unrelated hematopoietic stem cell donation., Blood, 121, 1469, 10.1182/blood-2012-06-437343 Gragert, 2014, HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry., N Engl J Med, 371, 339, 10.1056/NEJMsa1311707 Ciceri, 2008, A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation., Blood, 112, 3574, 10.1182/blood-2008-02-140095 Rizzieri, 2007, Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution., J Clin Oncol, 25, 690, 10.1200/JCO.2006.07.0953 Ciurea, 2010, Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT., Bone Marrow Transplant, 45, 429, 10.1038/bmt.2009.189 Lu, 2006, Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation., Blood, 107, 3065, 10.1182/blood-2005-05-2146 Huang, 2009, Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation., Biol Blood Marrow Transplant, 15, 257, 10.1016/j.bbmt.2008.11.025 Wang, 2013, Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center., Cancer, 119, 978, 10.1002/cncr.27761 Di Bartolomeo, 2013, Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies., Blood, 121, 849, 10.1182/blood-2012-08-453399 Luznik, 2001, Durable engraftment of major histocompatibility complex-incompatible cells after nonmyeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide., Blood, 98, 3456, 10.1182/blood.V98.12.3456 O’Donnell, 2002, Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide., Biol Blood Marrow Transplant, 8, 377, 10.1053/bbmt.2002.v8.pm12171484 Kanarky, 2013, Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide., Sci Transl Med, 5, 211ra157, 10.1126/scitranslmed.3006960 Brunstein, 2011, Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts., Blood, 118, 282, 10.1182/blood-2011-03-344853 Ciurea, 2012, Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation., Biol Blood Marrow Transplant, 18, 1835, 10.1016/j.bbmt.2012.07.003 Solomon, 2012, Haploidentical transplantation using T cell replete peripheral blood stem cells and myeloablative conditioning in patients with high-risk hematologic malignancies who lack conventional donors is well tolerated and produces excellent relapse-free survival: results of a prospective phase II trial., Biol Blood Marrow Transplant, 18, 1859, 10.1016/j.bbmt.2012.06.019 Raiola, 2014, Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts., Biol Blood Marrow Transplant, 20, 1573, 10.1016/j.bbmt.2014.05.029 Bashey, 2013, T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation., J Clin Oncol, 31, 1310, 10.1200/JCO.2012.44.3523 Di Stasi, 2014, Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors., Biol Blood Marrow Transplant, 20, 1975, 10.1016/j.bbmt.2014.08.013 Przepiorka, 1995, 1994 Consensus conference on acute GVHD grading., Bone Marrow Transplant, 15, 825 Sullivan, 1991, Chronic graft-versus-host disease and other late complications of bone marrow transplantation., Semin Hematol, 28, 250 Giralt, 2009, Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research., Biol Blood Marrow Transplant, 15, 367, 10.1016/j.bbmt.2008.12.497 Kaplan, 1958, Nonparametric estimation for incomplete observations., J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Gooley, 1999, Estimation of failure probabilities in the presence of competing risks: new representations of old estimators., Stat Med, 18, 695, 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O Cox, 1972, Regression model and life-tables., J R Stat Soc, B, 34, 187 Armand, 2014, Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation., Blood, 123, 3664, 10.1182/blood-2014-01-552984 Eapen, 2010, Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis., Lancet Oncol, 11, 653, 10.1016/S1470-2045(10)70127-3 Brunstein, 2012, Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes., Blood, 119, 5591, 10.1182/blood-2011-12-400630 Marks, 2014, Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors., Haematologica, 99, 322, 10.3324/haematol.2013.094193 Weisdorf, 2014, Alternative donor transplantation for older patients with acute myeloid leukemia in first complete remission: a center for international blood and marrow transplant research-eurocord analysis., Biol Blood Marrow Transplant, 20, 816, 10.1016/j.bbmt.2014.02.020 Ciurea, 2009, High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation., Transplantation, 88, 1019, 10.1097/TP.0b013e3181b9d710 Spellman, 2010, The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure., Blood, 115, 2704, 10.1182/blood-2009-09-244525 Ciurea, 2011, Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation., Blood, 118, 5957, 10.1182/blood-2011-06-362111 Eapen, 2014, Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignancies., Biol Blood Marrow Transplant, 20, 1485, 10.1016/j.bbmt.2014.05.015